Department of Neurology, Otto-von-Guericke University Magdeburg, Germany, German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Faculty of Medicine, University of Southampton, U.K.
Clin Sci (Lond). 2017 May 1;131(10):1001-1013. doi: 10.1042/CS20170004. Epub 2017 Mar 27.
Non-amyloid cerebral small vessel disease (CSVD) and cerebral amyloid angiopathy (CAA) may be interrelated through the damaged basement membranes (BMs) and extracellular matrix changes of small vessels, resulting in a failure of β-amyloid (Aβ) transport and degradation. We analyzed BM changes and the pattern of deposition of Aβ in the walls of blood vessels in spontaneously hypertensive stroke-prone rats (SHRSP), a non-transgenic CSVD model. In 45 SHRSP and 38 Wistar rats aged 18 to 32 weeks: (i) the percentage area immunostained for vascular collagen IV and laminin was quantified; (ii) the capillary BM thickness as well as endothelial and pericyte pathological changes were analysed using transmission electron microscopy (TEM); and (iii) the presence of vascular Aβ was assessed. Compared with controls, SHRSP exhibited a significantly higher percentage area immunostained with collagen IV in the striatum and thalamus. SHRSP also revealed an age-dependent increase of the capillary BM thickness and of endothelial vacuoles (caveolae) within subcortical regions. Endogenous Aβ deposits in the walls of small blood vessels were observed in the cortex (with the highest incidence found within fronto-parietal areas), striatum, thalamus and hippocampus. Vascular β-amyloid accumulations were frequently detected at sites of small vessel wall damage. Our data demonstrate changes in the expression of collagen IV and of the ultrastructure of BMs in the small vessels of SHRSP. Alterations are accompanied by vascular deposits of endogenous Aβ. Impaired β-amyloid clearance along perivascular and endothelial pathways and failure of extracellular Aβ degradation may be the key mechanisms connecting non-amyloid CSVD and CAA.
非淀粉样脑小血管病 (CSVD) 和脑淀粉样血管病 (CAA) 可能通过小血管受损的基底膜 (BM) 和细胞外基质改变相互关联,导致β-淀粉样蛋白 (Aβ) 转运和降解失败。我们分析了自发性高血压卒中易感性大鼠 (SHRSP) 中 BM 变化和血管壁 Aβ沉积模式,SHRSP 是一种非转基因 CSVD 模型。在 45 只 SHRSP 和 38 只 Wistar 大鼠中(年龄 18 至 32 周):(i) 血管胶原 IV 和层粘连蛋白免疫染色的血管面积百分比进行定量;(ii) 使用透射电子显微镜 (TEM) 分析毛细血管 BM 厚度以及内皮和周细胞的病理变化;(iii) 评估血管 Aβ 的存在。与对照组相比,SHRSP 纹状体和丘脑的血管胶原 IV 免疫染色面积百分比明显更高。SHRSP 还显示出随年龄增长,皮质下区域毛细血管 BM 厚度和内皮空泡(小窝)增加。在大脑皮层(发现于额顶区域最高)、纹状体、丘脑和海马区的小血管壁中观察到内源性 Aβ 沉积物。血管 β-淀粉样蛋白积聚经常在小血管壁损伤部位检测到。我们的数据表明 SHRSP 中小血管胶原 IV 的表达和 BM 的超微结构发生变化。改变伴随着内源性 Aβ 的血管沉积。沿血管周和内皮途径的β-淀粉样蛋白清除受损和细胞外 Aβ 降解失败可能是连接非淀粉样 CSVD 和 CAA 的关键机制。